The Global Liposome Drug Delivery market industry is witnessing significant growth driven by the increasing demand for targeted drug delivery systems. US, NY, UNITED STATES, February 13 ...

As a result, the liposome platform holds tremendous promise in the future of targeted cancer therapeutics to improve drug delivery while minimizing unwanted systemic bystander effects. This review ...

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the ...

CNW/ -- (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and ...

Innovative Chronic Pain Treatment Receives IP Protection in India's $55 Billion Pharmaceutical Market HERZLIYA, Israel and CALGARY, AB, Feb. 18, 2025 /PRNewswire/ -- Innocan Pharma ...

Israel: Innocan Pharma Corporation has announced that it has been granted a patent in India covering a prolonged-release ...

liposome properties, such as size, surface charge and functionality, can be easily tuned. Polymeric nanocarriers can be categorized based on three drug-incorporation mechanisms. The first includes ...

I then worked within a newly established Drug Delivery Company (Lipoxen Technologies Ltd) for two years, developing their liposome drug delivery platform technology before moving into Academia to set ...

In the pharmaceuticals sector, Innocan developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management.

In the pharmaceuticals sector, it has developed a CBD-loaded liposome drug delivery platform for non-opioid pain management. In the wellness sector, Innocan markets a wide range of self-care and ...